The Ministry of Health on Tuesday reported 951 new cases, meaning that 400,228 people have now contracted the disease since the beginning of the outbreak. There are 8,820 cases that remain active, 962 of whom are in critical condition.
According to the ministry, 389 of the newly recorded cases were in the Riyadh region, 212 in the Makkah region, 144 cases were reported in the Eastern Province and 32 in the Madinah region.
In addition, 608 more patients have recovered from the disease, bringing the total to 384,635 recoveries.
#الصحة تعلن عن تسجيل (951) حالة إصابة جديدة بفيروس كورونا (كوفيد-19)، وتسجيل (8) حالات وفيات رحمهم الله، وتسجيل (608) حالة تعافي ليصبح إجمالي عدد الحالات المتعافية (384,635) حالة ولله الحمد. pic.twitter.com/U1wGhoLpm4
— و ز ا ر ة ا لـ صـ حـ ة السعودية (@SaudiMOH) April 13, 2021
Saudi Arabia reported eight more COVID-19-related deaths. The death toll now stands at 6,773.
The health authorities have so far conducted 15,919,088 PCR tests, with 61,853 carried out in the past 24 hours.
Saudi health clinics set up by the ministry as testing hubs or treatment centers have helped hundreds of thousands of people around the Kingdom since the outbreak of the coronavirus pandemic.
Among those testing hubs are Taakad (make sure) centers and Tetamman (rest assured) clinics.
Taakad centers provide COVID-19 testing for those who show no or mild symptoms or believe they have come into contact with an infected individual, while the Tetamman clinics offer treatment and advice to those with virus symptoms, such as fever, loss of taste and smell, and breathing difficulties.
Appointments to either services can also be made through the ministry’s Sehhaty app.
Meanwhile, the Ministry of Health clarified the required measures in the event of a high body temperature following the COVID-19 vaccine.
The ministry said, in this case, it is possible to take a pain killer and antipyretic such as paracetamol when necessary, with the appropriate dose for the case, noting that common side effects after vaccine administration include fatigue, headache, pain at the injection site, muscle pain, tiredness, a high temperature and shivering.
This came in response from the ministry, through its official account on Twitter, to a question about the AstraZeneca vaccine and the accompanying symptoms.
